☆
4.7
Meeting Abstract
Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+(IHC3+) gastric carcinoma (GC).
JOURNAL OF CLINICAL ONCOLOGY (2019)
评价这篇论文
主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now